Stockreport

Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF This compares to loss of $3.78 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -25.4 [Read more]